1,594
Participants
Start Date
March 4, 2019
Primary Completion Date
December 10, 2019
Study Completion Date
December 10, 2019
AXS-07 (MoSEIC meloxicam and rizatriptan)
AXS-07 taken once upon onset of a qualifying migraine.
Meloxicam
Meloxicam taken once upon onset of a qualifying migraine.
Rizatriptan
Rizatriptan taken once upon onset of a qualifying migraine.
Placebo
Placebo taken once upon onset of a qualifying migraine.
Clinical Research Site, New York
Clinical Research Site, The Bronx
Clinical Research Site, Endwell
Clinical Research Site, Manlius
Clinical Research Site, Williamsville
Clinical Research Site, Rochester
Clinical Research Site, Philadelphia
Clinical Research Site, Charlottesville
Clinical Research Site, Norfolk
Clinical Research Site, Wilmington
Clinical Research Site, High Point
Clinical Research Site, Charleston
Clinical Research Site, Mt. Pleasant
Clinical Research Site, Stockbridge
Clinical Research Site, Atlanta
Clinical Research Site, Atlanta
Clinical Research Site, Fernandina Beach
Clinical Research Site, Lake City
Clinical Research Site, Ormond Beach
Clinical Research Site, Jacksonville
Clinical Research Site, DeLand
Clinical Research Site, Orange City
Clinical Research Site, Orlando
Clinical Research Site, Hallandale
Clinical Research Site, Hialeah
Clinical Research Site, Hollywood
Clinical Research Site, South Miami
Clinical Research Site, Miami
Clinical Research Site, Sunrise
Clinical Research Site, Lake Worth
Clinical Research Site, Tampa
Clinical Research Site, Clermont
Clinical Research Site, Ocoee
Clinical Research Site, Birmingham
Clinical Research Site, Birmingham
Clinical Research Site, Mobile
Clinical Research Site, Nashville
Clinical Research Site, Knoxville
Clinical Research Site, Memphis
Clinical Research Site, Louisville
Clinical Research Site, Lexington
Clinical Research Site, Dublin
Clinical Research Site, Cleveland
Clinical Research Site, Cincinnati
Clinical Research Site, Ann Arbor
Clinical Research Site, Minneapolis
Clinical Research Site, Evanston
Clinical Research Site, Kansas City
Clinical Research Site, Springfield
Clinical Research Site, Lenexa
Clinical Research Site, New Orleans
Clinical Research Site, Little Rock
Clinical Research Site, Oklahoma City
Clinical Research Site, San Antonio
Clinical Research Site, Austin
Clinical Research Site, Meridian
Clinical Research Site, Salt Lake City
Clinical Research Site, Phoenix
Clinical Research Site, Tempe
Clinical Research Site, Albuquerque
Clinical Research Site, Las Vegas
Clinical Research Site, Los Angeles
Clinical Research Site, Culver City
Clinical Research Site, Santa Monica
Clinical Research Site, Los Alamitos
Clinical Research Site, Canoga Park
Clinical Research Site, Encino
Clinical Research Site, Pomona
Clinical Research Site, Spring Valley
Clinical Research Site, San Diego
Clinical Research Site, Redlands
Clinical Research Site, Colton
Clinical Research Site, Riverside
Clinical Research Site, Oceanside
Clinical Research Site, Walnut Creek
Clinical Research Site, Portland
Clinical Research Site, Salem
Clinical Research Site, Bellevue
Clinical Research Site, Seattle
Clinical Research Site, Waterbury
Clinical Research Site, Boston
Clinical Research Site, North Dartmouth
Clinical Research Site, Watertown
Clinical Research Site, Berlin
Clinical Research Site, Toms River
Lead Sponsor
Axsome Therapeutics, Inc.
INDUSTRY